Related Experiment Video

Updated: Jun 19, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials

Nick Freemantle1, Thomas Strack

  • 1School of Health and Population Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. n.freemantle@bham.ac.uk

Journal of Clinical Epidemiology
|November 3, 2009
PubMed
Abstract

Insights

Real-world trials (RWTs) offer valuable insights into medical intervention effectiveness beyond conventional randomized controlled trials (RCTs). Properly designed RWTs enhance understanding for patients and healthcare providers.

Area of Science:

  • Clinical trial methodology
  • Evidence-based medicine
  • Health services research

Background:

  • Growing demand from healthcare providers, policymakers, and patients for clinical trial outcomes.
  • Conventional phase 3 trials often do not address the specific questions of interest to these stakeholders.
  • Need for improved study designs to assess real-world effectiveness and safety.

Purpose of the Study:

  • To explore the methodological considerations for designing effective real-world trials (RWTs).
  • To enhance the relevance and generalizability of clinical trial findings.
  • To inform patients and healthcare providers with more applicable evidence.

Main Methods:

  • Review of methodological articles on clinical trial design.
  • Analysis of factors contributing to the external validity of studies.
  • Focus on improving phase 3b and phase 4 study designs.

Main Results:

  • Conventional randomized controlled trials (RCTs) prioritize internal validity over external validity (generalizability).
  • Real-world trials (RWTs) aim to address uncertainties in effectiveness and safety in routine clinical practice.
  • Key factors for RWTs include relevant endpoints, appropriate patient selection, and flexible study procedures while maintaining randomization.

Conclusions:

  • Real-world trials (RWTs) are not intended to replace conventional RCTs.
  • Well-designed RWTs significantly enhance the understanding of healthcare intervention effectiveness.
  • RWTs provide crucial information to better support patients and healthcare providers in decision-making.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).